PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
846.15%
Net income growth above 1.5x MRVL's 92.00%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-2.04%
Negative yoy D&A while MRVL is 2.32%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
13.51%
Lower deferred tax growth vs. MRVL's 71.43%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
8.33%
SBC growth while MRVL is negative at -14.20%. John Neff would see competitor possibly controlling share issuance more tightly.
-270.00%
Both reduce yoy usage, with MRVL at -93.07%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
62.71%
AR growth is negative or stable vs. MRVL's 253.90%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
666.67%
Inventory growth well above MRVL's 205.80%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-62.96%
Both negative yoy AP, with MRVL at -977.86%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-409.38%
Both reduce yoy usage, with MRVL at -95.97%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-65.12%
Negative yoy while MRVL is 657.37%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
56.44%
Operating cash flow growth below 50% of MRVL's 150.50%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
29.17%
CapEx growth well above MRVL's 47.42%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Both yoy lines negative, with MRVL at -162.50%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-36.03%
Both yoy lines negative, with MRVL at -103.77%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-25.98%
We reduce yoy sales while MRVL is 60.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-79.17%
Both yoy lines negative, with MRVL at -78.69%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-180.57%
Both yoy lines negative, with MRVL at -90.66%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Repurchase growth above 1.5x MRVL's 62.76%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.